Pune, India, October, 2018 /press release/- Market Research Future Published a Half-Cooked Research Report on Hearing Screening and Diagnostic Devices Market Research Report
The global hearing screening and diagnostic devices market is presumed to exhibit a CAGR of 8.5 % during the forecast period (2018-2023) owing to the growing geriatric population, asserts Market Research Future (MRFR). Hearing screening and diagnostic devices are the instruments used to treat deafness. Hearing loss can arise from non-heredity factors and heredity factors due to certain complications at the time of childbirth or pregnancy. Chronic ear infections, meningitis or measles can cause hearing impairment.
Drivers and Constraints Impacting the Market
The increasing level of noise pollution has affected the global population to a great extent. Loud music systems during any festive occasion along with noise created by the traffic are major causes of hearing loss. Factors such as growing geriatric population, increasing patient pool due to birth complications, ear infections, and genetic disorders are propelling the market growth during the assessment period. Besides, government funding in clinical research and continuous technological developments in medical devices are further driving the market. For instance, the advent of cochlear implants has brought revolution in the hearing screening and diagnostic devices. The use of hearing screening and diagnostic devices has gained importance due to its potential to improve the quality of life.
On the flip side, unavailability of proper healthcare infrastructure and unaffordability of such devices in the middle-income countries are considered to impact the market negatively. Moreover, lack of awareness about the disease and high cost of the implant devices are likely to retard the growth of the market in the coming years.
Global Hearing Screening and Diagnostic Devices Market: Segmental Analysis
The global hearing screening and diagnostic devices market has been segmented on the basis of product, test, indication, and region.
By mode of product, the global hearing screening and diagnostic devices market is segmented into audiometric examination devices, screening devices, and others. Audiometric examination devices are sub-segmented into screening audiometer and diagnostic audiometer. Screening devices are further sub-segmented into screening audiometers, OAE/ABR testing devices, immittance screeners, and others.
By mode of test, the global hearing screening and diagnostic devices market is segmented into speech discrimination test, speech reception threshold test (SRT), test for middle ear, most comfortable listening level test (MCL), uncomfortable loudness level test (UCL), pure-tone test, bone conduction test, and others. Among these, the test for middle ear is further sub-segmented into tympanometry tests, static acoustic impedance, and acoustic reflex measures. Pure-tone test is sub-segmented into conditioned play audiometry and visual reinforcement audiometry.
By mode of indication, the global hearing screening and diagnostic devices market has been segmented into sensorineural hearing loss, conductive hearing loss, combination hearing loss, and others.
By mode of end-users, the global hearing screening and diagnostic devices market has been segmented into personal use, hospitals and clinics, and ambulatory care settings.
Geographically, the hearing screening and diagnostic devices market span across regions namely, Asia Pacific, Europe, America, and the Middle East and Africa.
Among all the regions, the American region accounts for the largest market share owing to the growing patient population with hearing impairment. For instance, as per the National Institute on Deafness and Other Communication Disorders, around 15 % of the adults in America aged 18 and above report trouble in hearing. Moreover, the availability of advanced healthcare facilities and awareness about good health is driving the market in this region. With the increased funding for research, rising government initiatives, growing awareness associated with the adverse effects of ear infection, and rising newborn screening for hearing impairment issues are likely to accelerate the market growth in this region.
Europe is anticipated to be the second largest market and is expected to hold a healthy share in the global market owing to the established healthcare infrastructure, availability of advanced treatment facilities, and growing patient pool. Also, increasing funding for R&D activities is likely to propel the market growth in this region.
Asia Pacific is considered to be the fastest growing market owing to the growing prevalence of acquired diseases and an increasing number of infants with hearing impairments. Additionally, changing lifestyle, increasing expenditure on healthcare, and technological advancements in medical science are some of the major factors augmenting the market growth in this region.
March 03, 2018: Cochlear Limited, a leading global company for implantable hearing solutions, has recently announced joining forces with the WHO and international hearing care community members to raise awareness regarding hearing loss on World Hearing Day. The cost-effective actions reinforced by WHO & Cochlear jointly comprised identification of hearing loss early through screening of new-born, adults and school children and spreading the awareness about the importance of early diagnosis.